Pharmaceutical Industry Information Portal

HomeTagsRDIF

All posts by tag

RDIF

Sputnik V has demonstrated 97.8% efficacy against COVID-19 in UAE

Efficacy among more than 81,000 subjects who had received both components of Sputnik V was 97.8%. Analysis is based on the data collected by June 8, 2021.

Test batch of the Sputnik V vaccine produced in Iran

The production of Sputnik V, a vaccine for the coronavirus developed by Russia, began at an Iranian company on Saturday, 26 June. In a...

Sputnik V demonstrates 94.3% efficacy during the vaccination campaign in Bahrain

An efficacy study was conducted in Bahrain in accordance with WHO guidelines involving more than 5,000 subjects. Overall efficacy beyond 14 days after administering the second dose was estimated at 94.3%.

Brazil becomes the 67th country in the world to authorize Sputnik V vaccine

The vaccine was authorized for import and use by Brazilian states after ANVISA considered the technical report provided by Russia’s Health Ministry.

RDIF and Sanofi to develop digital healthcare solutions in Russia

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Sanofi, one of the leading global pharmaceutical companies, agree to cooperate for joint...

RDIF, Mumtalakat and Binnopharm Group to establish production of the Sputnik V in Bahrain

The MoU was signed on the sidelines of the St. Petersburg International Economic Forum. Bahrain authorized the emergency use of Sputnik V In Feb. 2021.
spot_img

Expert Articles

spot_img